Skip to main navigation
Theratechnologies Announces Completion of Acquisition by Future Pak.
Click here
to learn more.
About
About
About Us
Medicines & Pipeline
Medicines & Pipeline
Medicines
Trogarzo
®
EGRIFTA SV
®
/WR
™
Pipeline & Science
HIV
Scientific Papers
Patient Information
Expanded Access Policy
Grants/ISRs/IITs
IR Nav
News
Compliance, Ethics & Privacy
Compliance, Ethics & Privacy
Compliance
California Declaration
Report on Modern Slavery
Ethics
Code of Business Conduct and Ethics
Anti-Bribery and Corruption Policy
Privacy
Careers
Careers
Contact Us
Contact Us
en
en
fr
btn Alerts
Sign up for Email Alerts
Social icons
Search
Search
Asset
Theratechnologies To Announce Financial Results For Its First Quarter Fiscal 2021
Télécharger le communiqué
63.7 KB
Asset
Theratechnologies resumes distribution of EGRIFTA® (Tesamorelin for injection) in the United States
Theratechnologies resumes distribution of EGRIFTA® (Tesamorelin for injection) in the United States
117.8 KB
Search
Theratechnologies
×
Search
Search